Robot Assisted Minimally Invasive Esophagectomy (RAMIE)

Esophageal cancer is the sixth most common cause of cancer death worldwide, with occurrence rates varying greatly by geographic location [1]. The standard treatment for locally advanced esophageal cancer with curative intent is multimodality treatment containing either preoperative chemoradiation or perioperative chemotherapy followed by open esophagectomy [2, 3]. However, the open transthoracic esophagectomy is associated with high morbidity and mortality [4, 5].